Back

Changes over time in AI-based echocardiographic metrics before and after therapy in ATTR cardiomyopathy

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Amely Walser

University Hospital Zurich, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort
Doctor M. Desai (Cleveland, US)
Abstract
Presentation thumbnail
Genetic status and response patterns to mavacamten: an echocardiographic signature of reverse remodeling from 3 portuguese centers
Doctor I. Miranda (Amadora, PT)
Abstract
Presentation thumbnail
Musculoskeletal events and risk of amyloidosis in the general population
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Abstract
Presentation thumbnail
Circulating transthyretin as an independent systemic vulnerability signal in transthyretin amyloidosis: insights from the French HEAR Registry
Assistant Professor A. Zaroui (Creteil, FR)
Abstract
Presentation thumbnail
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Artificial intelligence to assist the echocardiographic identification of transthyretin cardiac amyloidosis
30 August 2024
thumbnail
Congress Presentation
Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis
18 May 2025
thumbnail
Congress Presentation
Cardiac MRI as a possible alternative to echocardiography for therapeutic response monitoring in ATTR cardiomyopathy: a multiparametric evaluation in patisiran treated patients
11 May 2023
thumbnail
Congress Presentation
Atrial structure and function in patients with amyloidosis: findings from the NEURO-TTRansform study.
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources